LICHTINGER PEDRO
Insider CIK 1470741 · OPTR CEO and President, Director · NONE President & CEO, Director · GEMP Director · BTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GEMP Gemphire Therapeutics Inc. | A Award | 2019-07-24 | 2019-07-26 | 15,000 | — | $0 | 74,833 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2018-01-29 | 2018-01-30 | 10,800 | — | $0 | 10,800 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy deriv | 2017-03-10 | 2017-03-14 | 7,920 | $9.47 | $75.0K | 7,920 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy | 2017-03-10 | 2017-03-14 | 10,559 | $9.47 | $100.0K | 59,833 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion deriv | 2016-08-10 | 2016-08-12 | 0 | — | $0 | 0 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy | 2016-08-10 | 2016-08-12 | 10,000 | $10.00 | $100.0K | 49,274 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion | 2016-08-10 | 2016-08-12 | 39,274 | $6.71 | $263.5K | 39,274 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2016-08-04 | 2016-08-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AST Asterias Biotherapeutics, | A Award deriv | 2016-01-18 | 2016-01-19 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AST Asterias Biotherapeutics, | A Award deriv | 2015-02-13 | 2015-02-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AST Asterias Biotherapeutics, | A Award deriv | 2015-02-13 | 2015-02-18 | 23,932 | — | $0 | 23,932 | SEC↗ |
| AST Asterias Biotherapeutics, | P Buy | 2015-02-09 | 2015-02-11 | 128,205 | $3.90 | $500.0K | 528,205 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2014-07-01 | 2014-07-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NONE Asterias Biotherapeutics, | A Award | 2014-06-12 | 2014-06-16 | 200,000 | $2.34 | $468.0K | 400,000 | SEC↗ |
| NONE Asterias Biotherapeutics, | J Other deriv | 2014-06-09 | 2014-06-11 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| NONE Asterias Biotherapeutics, | A Award deriv | 2014-06-09 | 2014-06-16 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| NONE Asterias Biotherapeutics, | J Other | 2014-06-09 | 2014-06-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NONE Asterias Biotherapeutics, | A Award | 2014-06-09 | 2014-06-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2013-07-01 | 2013-07-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BTX BIOTIME INC | P Buy deriv | 2013-06-04 | 2013-06-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BTX BIOTIME INC | P Buy | 2013-06-04 | 2013-06-06 | 120,000 | — | $0 | 126,250 | SEC↗ |
| OPTR OPTIMER PHARMACEUTICALS IN | M Exercise deriv | 2013-04-08 | 2013-04-10 | 90,000 | — | $0 | 0 | SEC↗ |
| OPTR OPTIMER PHARMACEUTICALS IN | M Exercise deriv | 2013-04-08 | 2013-04-10 | 58,000 | — | $0 | 0 | SEC↗ |
| OPTR OPTIMER PHARMACEUTICALS IN | S Sale | 2013-04-08 | 2013-04-10 | 90,000 | $14.73 | $1.33M | 104,078 | SEC↗ |
| OPTR OPTIMER PHARMACEUTICALS IN | M Exercise | 2013-04-08 | 2013-04-10 | 58,000 | $11.41 | $661.8K | 162,078 | SEC↗ |
| OPTR OPTIMER PHARMACEUTICALS IN | M Exercise | 2013-04-08 | 2013-04-10 | 90,000 | $13.51 | $1.22M | 252,078 | SEC↗ |
| OPTR OPTIMER PHARMACEUTICALS IN | S Sale | 2013-04-08 | 2013-04-10 | 58,000 | $14.63 | $848.5K | 194,078 | SEC↗ |
| OPTR OPTIMER PHARMACEUTICALS IN | P Buy | 2012-11-08 | 2012-11-19 | 11,000 | $9.08 | $99.9K | 104,078 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2012-07-01 | 2012-07-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OPTR OPTIMER PHARMACEUTICALS IN | J Other | 2012-05-15 | 2012-05-17 | 2,185 | $9.72 | $21.2K | 93,078 | SEC↗ |
| BTX BIOTIME INC | P Buy | 2012-04-11 | 2012-04-12 | 6,250 | $3.98 | $24.9K | 6,250 | SEC↗ |
| OPTR OPTIMER PHARMACEUTICALS IN | A Award deriv | 2012-02-07 | 2012-02-09 | 120,000 | — | $0 | 120,000 | SEC↗ |